What question did this study set out to answer?

The study aims to evaluate molecular predictors of outcomes in early non-squamous non-small cell lung cancer (NSCLC).

February 22, 2026Pathology0 citations

Molecular predictors of outcome in early non-squamous non-small cell lung cancer

Key Points

The study aims to evaluate molecular predictors of outcomes in early non-squamous non-small cell lung cancer (NSCLC).
Utilized a 50-gene panel for next-generation sequencing in resected lung cancers
Examined the incidence of driver mutations in early NSCLC
Analyzed the prognostic significance of identified alterations
Identified key driver mutations that influence clinical outcomes
Demonstrated the importance of molecular testing in treatment planning
Outlined the prevalence and implications of findings for future NSCLC management

Abstract

The 2025 RCPA consensus guideline recommends routine molecular testing of key driver alterations in early non-squamous non-small cell lung cancer (NSCLC). Since 2020, the Northern Sydney Local Health District has implemented next-generation sequencing using a 50-gene panel for all resected lung cancers. We examined the incidence of driver mutations and their prognostic significance in this population.

问 AI

Bookmark

View Full Paper

Cite This Study

Chan et al. (Sun,) studied this question.

synapsesocial.com/papers/699a534bfdaf4e3c1268ee08 https://doi.org/https://doi.org/10.1016/j.pathol.2026.01.041

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

问 AI

Bookmark

View Full Paper